models of mHRPC
cancer research
relevant metastasis microenvironment
metastatic hormone-refractory prostate cancer
therapy resistance of metastatic cancer
unique bone metastasis microenvironment
role of tumour microenvironment
field of cancer medicine research
role of tumor microenvironment
preclinical research
mouse models
human disease
disease progression
disease outcome
standard preclinical models
state-of-the-art tumour models
androgen dependent PC bone metastasis model
lethal form
findings
innovative adoptive transfer approach
innovative therapeutic approaches
PC related deaths
multidisciplinary approach
new standards
lethal threat
new therapeutics
patient care
marginal patient benefit
dynamic ADT resistance reporter system
intra-vital microscopy
genetic tools of lineage specific knockout
stromal cells
mimics
challenge
area
number
goal
step change
common malignancy
underlying molecular mechanisms
pathology
project
key element
development
proposal
preliminary data
European societies
patients
MetResistance
understanding
work